| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2022―Aug―25 |
Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes |
Luay Alkazmi, Hayder M. Al-kuraishy, Gaber El-Saber Batiha, Gomaa Mostafa-Hedeab, Michel De Waard, Jean-Marc Sabatier, Saeed M. Kabrah, Hebatallah M. Saad, Ali I. Al-Gareeb, Jesus Simal-Gandara |
| 2 |
[GO] |
2022―Aug―24 |
Novel Strategies for the Treatment of COVID-19 |
Matthew W. McCarthy |
| 3 |
[GO] |
2021―Aug―05 |
Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 |
Rosanne Sprute, Sofie Schumacher, Martina Pauls, Wolfgang Pauls, Oliver A. Cornely |
| 4 |
[GO] |
2021―Jul―29 |
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor |
Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y. J. Zhang, Mirza S. Baig |
| 5 |
[GO] |
2021―Jun―21 |
Potential for the Repurposing of Adamantane Antivirals for COVID-19 |
Roger F. Butterworth |
| 6 |
[GO] |
2021―Jun―09 |
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? |
Reinhart Speeckaert, Jo Lambert, Luis Puig, Marijn Speeckaert, Hilde Lapeere, Sofie De Schepper, Nanja van Geel |
| 7 |
[GO] |
2020―Dec―17 |
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment |
Fiona Marra, Elise J. Smolders, Omar El-Sherif, Alison Boyle, Katherine Davidson, Andrew J. Sommerville, Catia Marzolini, Marco Siccardi, David Burger, Sara Gibbons, Saye Khoo, David Back |
| 8 |
[GO] |
2020―Dec―01 |
Dosing Considerations for Antibodies Against COVID-19 |
Million A. Tegenge, Iftekhar Mahmood, Evi Struble, Basil Golding |
| 9 |
[GO] |
2020―Jun―26 |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells |
Mirza S. Baig, Manikandan Alagumuthu, Sajjan Rajpoot, Uzma Saqib |
|
